Professional Documents
Culture Documents
Abnormal
Uterine
Bleeding
Causes, Evaluation and Treatment
PALMCOEIN
Introduced by FIGO
Supported by ACOG
Create consistency in research
Help define roles in diagnosis and
treatment
Help standardize the approach
Termsabandonedinthe
FIGOnomenclaturesystem
9/28/2012
Clinicaldimensionsofmenstruation
andmenstrualcycle
Frequencyofmenses,d
Frequent
<24
Normal
2438
Infrequent
>38
Clinicaldimensionsofmenstruationand
menstrualcycle
Regularityofmenses:
cycletocyclevariation
over12months,d
Absent
Nobleeding
Regular
Variation 220
Irregular
Variation>20
Clinicaldimensionsofmenstruationand
menstrualcycle
Durationofflow,d
Prolonged
>8.0
Normal
4.58.0
Shortened
<4.5
9/28/2012
Clinicaldimensionsofmenstruationand
menstrualcycle
Volumeofmonthly
bloodloss,mL
Heavy
>80
Normal
580
Light
<5
COEIN
Structural
Polyp
Adenomyosis
Leiomyoma
Malignancy
9/28/2012
PALM
Nonstructural
Coagulopathy
Ovulatory dysfunction
Endometrial
Iatrogenic
Not yet classified
PALMCOEIN
No place for dysfunctional uterine bleeding
DUB
PALMCOEIN
9/28/2012
Workup
History
Use descriptive scheme
Pain
Family history of AUB or bleeding
disorder
o 20% will have an underlying bleeding
disorder
Meds
Herbs
Meds
Warfarin
Heparin
NSAID
OCPs
9/28/2012
Herbs
Ginko
Ginseng
Motherwort
9/28/2012
Exam
Overweight
PCOS signs
o Acne
o Hirsutism
9/28/2012
Exam
Overweight
PCOS signs
o Acne
o Hirsutism
Thyroid nodule
9/28/2012
Exam
Overweight
PCOS signs
o Acne
o Hirsutism
Thyroid nodule
Insulin resistance
o Acanthosis nigricans on neck
Exam
Overweight
PCOS signs
o Acne
o Hirsutism
Thyroid nodule
Insulin resistance
o Acanthosis nigricans on neck
9/28/2012
Pelvic
Cervical or vaginal lesions
o Biospy?
Uterine size
Uterine contour
10
9/28/2012
Lab
UPT
CBC
Screening for bleeding disorders (when
indicated)
TSH
Chlamydia
Imagingetc
US
Saline infusion US
MRI
Hysteroscopy
EMB
AgeBreakdown
13-18
o Hypothalamic-Pituitary-Ovarian
access immature
o OCP
o Pregnancy
o Pelvic infection
o Coagulopathies
o Tumor
11
9/28/2012
AgeBreakdown
19-39
o Pregnancy
o Polyp
o Leiomyoma
o Anovulation (PCOS)
o Hormonal contraceptives
o Hyperplasia
o Less commonly cancer
AgeBreakdown
40
o Anovulatory bleeding
o Hyperplasia
o Cancer
o Endometrial atrophy
o Leiomyoma
Imaging
No clear advantage in initial
workup
TVUS if persistent
Endometrial thickness in
premenopausal patient is not
helpful
12
9/28/2012
Imaging
TVUS great for myometrial evaluation
SIS great for evaluation of endometrial cavity
46% have something abnormal about the cavity
3D some evidence that it helps determine the
depth of myometrial invasion of leiomyoma
MRI weigh cost and benefits
o Prior to myomectomy?
o Prior to UAE
o HIFU
Biopsy
Over 45 - definitely
Younger
o If unopposed estrogen
PCOS
Obese
o Failed medical management
o Persistent AUB
Positive predicative value better than negative
predicative value
Biopsy
Only an endpoint if
oCancer
oAtypical hyperplasia
13
9/28/2012
AUBP
Polyp
Hysteroscopy
AUBA
Adenomyosis
MRI
US
o Heterogeneous
o Myometrial cysts
o Asymmetrical myometrial thickness
o Subendometrial echogenic linear
striations
14
9/28/2012
AUBE
15
9/28/2012
Rx
Low risk patients
o Trial of meds
NSAIDs
Progestins
OCPs
Levonorgestrel IUD
Tranexamic acid
ProbabilityofHysterectomyAfter
EndometrialAblation
Mindyn K.Longinotti,MD,GavinF.
Jacobson,MD, YunYiHung,PhD,andLee
A.Learman,MD,PhD
N ~ 4000
Kaiser patients
Did not include laser or Cryo
26% went to hysterectomy
Eight year follow up
16
9/28/2012
Fig.1
Copyright 2012 Obstetrics & Gynecology. Published by Lippincott Williams & Wilkins.
49
Leiomyomas
Hysterectomy
OR
17
9/28/2012
Leiomyomas
Contraceptive steroids
NSAIDs
GnRH agonists
Aromatase inhibitors
Progesterone modulators
Leiomyomas
Myomectomy
o Open
o Laparoscopy
o Robot
o Hysteroscopy
UAE
mrHIFU
Caveats
Preop GnRH agonist
GnRH antagonist
o No steroid flare
Vasopressin
18
9/28/2012
Myomectomy
CS??????
Myomectomy
CS??????
No clinical trials
1 rupture in 750 pooled laparoscopic
myomectomies
Maintain a high index of suspicion
Myomectomy
Help with future conception?
Myomas present in 5-10% of infertility
patients
Sole identifiable factor in 1-2.4%
IVF patients with submucous myomas
seem to benefit
19
9/28/2012
Myomectomy
Recurrence
Adhesions
UAE
Ovarian failure
Increased risk with age
12% placentation problems
o Previa
o Accreta
mrHIFU
Studies comparing to
myomectomy ongoing
20
9/28/2012
Highintensityfocused
ultrasoundtreatmenton70
uterinefibroids:efficacyand
safety
Mayinuer Niyazi,Haiyan Sun,Yan
Li,Shuhua Huang,WeiWang
Gynaecology,PeoplesHospitalof
XinjiangVvgur Autonomous
Region,China
mrHIFU
Actually 70 patients
FDA approved
Trial going on in patients desiring future
pregnancy
Myomectomy is comparison group
Results may be a year or more
21
9/28/2012
ExperimentalTherapy
MotyPansky,BryanD.Cowan,MayaFrank,HarrietteL.Hampton,StephenZimberg
Laparoscopicallyassisteduterinefibroidcryoablation
AmericanJournalofObstetricsandGynecologyVolume201,Issue62009571.e1 571.e7
http://dx.doi.org/10.1016/j.ajog.2009.06.028
22
9/28/2012
MotyPansky,BryanD.Cowan,MayaFrank,HarrietteL.Hampton,StephenZimberg
Laparoscopicallyassisteduterinefibroidcryoablation
AmericanJournalofObstetricsandGynecologyVolume201,Issue62009571.e1 571.e7
http://dx.doi.org/10.1016/j.ajog.2009.06.028
23
9/28/2012
24
9/28/2012
MotyPansky,BryanD.Cowan,MayaFrank,HarrietteL.Hampton,StephenZimberg
Laparoscopicallyassisteduterinefibroidcryoablation
AmericanJournalofObstetricsandGynecologyVolume201,Issue62009571.e1 571.e7
http://dx.doi.org/10.1016/j.ajog.2009.06.028
25
9/28/2012
26
9/28/2012
Prevalence
27